# Phase 2 — MuJoCo Physics Backend Completion Record

**Status:** Complete  
**Scope authority:** Master specification, Phase 2 and Sections 9–10  
**Completion date:** 2026-08-26

## Delivered boundary

The existing primary MuJoCo backend was reviewed and accepted as the Phase 2 implementation. It loads the version-controlled MJCF hand model, resets deterministically, advances fixed headless steps, exposes a backend-neutral simulation-state snapshot, restores compatible snapshots, accepts only named bounded joint targets, rejects unsupported or unsafe targets before stepping, and releases resources cleanly.

The implementation keeps decision, controller, safety-policy, and task semantics outside the backend. MuJoCo remains the primary simulator; no backend substitution was made.

## Acceptance evidence

| Requirement | Evidence | Result |
|---|---|---|
| Model load | `MujocoBackend.load_model` loads `assets/models/hand.xml` and exposes documented controllable joints | Passed |
| Deterministic reset and headless step | Fixed controls, identical seed, and 100 headless steps produce identical state vectors to `1e-12` absolute tolerance | Passed |
| State read and restoration | A snapshot restored after additional stepping reproduces position, velocity, control, and time | Passed |
| Bounded named command handling | Unknown joints and actuator/joint-range violations fail before physics stepping | Passed |
| Model validation smoke run | `myosim validate-model --model assets/models/hand.xml` returned 2 ms timestep and `invalid_state: false` | Passed |

## Commands executed

```bash
pytest -q --no-cov tests/integration/test_mujoco_backend.py tests/unit/test_model_asset.py
myosim validate-model --model assets/models/hand.xml
```

The focused acceptance suite completed with **6 passed** tests. The command-line smoke run reported the controllable joints `forearm_x`, `forearm_y`, `thumb_flex`, `index_flex`, `middle_flex`, and `ring_flex`, with no invalid state.

## Gate decision

**Phase 2 is complete.** The Phase 3 decision-engine gate may proceed. No clinical, hardware, or clinical-safety claim follows from this simulation validation.
